Phase 2 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with COPD:
- A person must have a COPD diagnosis confirmed by a breathing test showing a specific airflow ratio (FEV1/FVC) below the normal lower limit after using a bronchodilator
- A person's lung function (FEV1) must be above 30% of what is expected for someone of their age, height, and sex
For healthy comparison participants (people without COPD):
- A person must not have a COPD diagnosis
- A person must have a breathing test result (FEV1/FVC ratio) above the normal lower limit after using a bronchodilator
- A person's lung function (FEV1) must be above 80% of what is expected for someone of their age, height, and sex
Who may not be able to join:
- People who have a medical reason why exercise testing would be unsafe, or who have a bone or joint condition that could limit their ability to exercise during testing
- People with pre-existing heart conditions — such as heart failure, a heart defect present from birth, or a heart valve problem — that could limit exercise testing
- People who had a diagnosis of high blood pressure in the lungs (pulmonary hypertension) before their COPD diagnosis
- People currently taking certain medications, including phosphodiesterase type-5 inhibitors, nitrates, opioids, azole antifungals, macrolide antibiotics, protease inhibitors, alpha blockers, riociguat, mifepristone, or rifamycin (confirm with trial site if unsure whether a current medication is on this list)
- People who are pregnant or breastfeeding
- Women who could become pregnant and are not willing to use an accepted form of contraception (such as tubal ligation, the contraceptive pill, an IUD, a diaphragm, or condoms) for the duration of the study
- Women who have gone through menopause must have had no menstrual period for 12 months or more
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael K Stickland, Ph.D., University of Alberta
Phone: 7804921121
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Exercise Capacity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.